| SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies CO Barnes, CA Jette, ME Abernathy, KMA Dam, SR Esswein, HB Gristick, ... Nature 588 (7839), 682-687, 2020 | 1570 | 2020 |
| mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... Nature 592 (7855), 616-622, 2021 | 1542 | 2021 |
| Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques A Escolano, HB Gristick, ME Abernathy, J Merkenschlager, R Gautam, ... Nature 570 (7762), 468-473, 2019 | 157 | 2019 |
| Restriction of HIV-1 escape by a highly broad and potent neutralizing antibody P Schommers, H Gruell, ME Abernathy, MK Tran, AS Dingens, HB Gristick, ... Cell 180 (3), 471-489. e22, 2020 | 125 | 2020 |
| Histidine-directed arylation/alkenylation of backbone N–H bonds mediated by copper (II) J Ohata, MB Minus, ME Abernathy, ZT Ball Journal of the American Chemical Society 138 (24), 7472-7475, 2016 | 124 | 2016 |
| Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein F Bianchini, V Crivelli, ME Abernathy, C Guerra, M Palus, J Muri, ... Science immunology 8 (81), eade0958, 2023 | 56 | 2023 |
| Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env A Escolano, HB Gristick, R Gautam, AT DeLaitsch, ME Abernathy, Z Yang, ... Science translational medicine 13 (621), eabk1533, 2021 | 39 | 2021 |
| Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies CO Barnes, CA Jette, ME Abernathy, KMA Dam, SR Esswein, HB Gristick, ... bioRxiv, 2020 | 37 | 2020 |
| Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies F Zhang, J Jenkins, RVH de Carvalho, S Nakandakari-Higa, T Chen, ... Nature Microbiology 8 (6), 1051-1063, 2023 | 14 | 2023 |
| CD4 binding site immunogens elicit heterologous anti–HIV-1 neutralizing antibodies in transgenic and wild-type animals HB Gristick, H Hartweger, M Loewe, J van Schooten, V Ramos, ... Science immunology 8 (80), eade6364, 2023 | 13 | 2023 |
| How antibodies recognize pathogenic viruses: structural correlates of antibody neutralization of HIV-1, SARS-CoV-2, and Zika ME Abernathy, KMA Dam, SR Esswein, CA Jette, PJ Bjorkman Viruses 13 (10), 2106, 2021 | 13 | 2021 |
| Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agents F Zhang, J Jenkins, RVH de Carvalho, S Nakandakari-Higa, T Chen, ... bioRxiv, 2022.08. 24.505169, 2022 | 8 | 2022 |
| Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope ME Abernathy, HB Gristick, J Vielmetter, JR Keeffe, PNP Gnanapragasam, ... npj Vaccines 6 (1), 126, 2021 | 6 | 2021 |
| Immunization expands HIV-1 V3-glycan specific B-cells in mice and macaques A Escolano, HB Gristick, ME Abernathy, J Merkenschlager, R Gautam, ... Nature 570 (7762), 468, 2019 | 4 | 2019 |
| mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.[DOI][PMC free article][PubMed][Academic Search] Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... | 2 | 2021 |
| Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies CO Barnes, CA Jette, ME Abernathy, KMA Dam, SR Esswein, HB Gristick, ... Nature 628 (8008), E2, 2024 | 1 | 2024 |
| Sequential Immunization Strategies to Elicit HIV-1 bNAbs in Animal Models With a Polyclonal B Cell Repertoire A Escolano, HB Gristick, R Gautam, J Merkenschlager, J Golijanin, ... AIDS Research and Human Retroviruses 34 (S1), 331, 2018 | 1 | 2018 |
| Engineering HIV immunogens to elicit IOMA-like antibodies targeting the CD4 binding site H Gristick, S Jv, H Hartweger AIDS Res Hum Retrovirus 34, S1, 2018 | 1 | 2018 |
| BPS2025-Structural design and characterization of prefusion-stabilized coronavirus S2 proteins in complex with antibodies A Rubio, M Abernathy, Y Lee, M Eso, D Robbiani, CO Barnes Biophysical Journal 124 (3), 51a-52a, 2025 | | 2025 |
| Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern AA Rubio, VA Baharani, B Dadonaite, M Parada, ME Abernathy, Z Wang, ... bioRxiv, 2024 | | 2024 |
